Quantifying Tuberculosis Burden and Underrepresentation. Nurhuda Ismail, Awang M Bulgiba, Sanjay Rampal,
|
|
- Hilary Harrison
- 5 years ago
- Views:
Transcription
1 Quantifying Tuberculosis Burden and Underrepresentation in Malaysia, Nurhuda Ismail, Awang M Bulgiba, Sanjay Rampal, Nicolaas JD Nagelkerke, Jiloris F. Dony, Omar Awang October 015
2 Contents 1. Introduction. Methods 3. Results 4. Discussion
3 Question: Does TB incidence data in Malaysiareflect Does TB incidence data in Malaysia reflect true burden?
4 Prevalence, incidence, and mortality rates per population in countries and areas with an intermediate burden of TB in the Western Pacific Region 006 Source: WHO Tuberculosis Control WPR Report, 008 4
5 Incidence Rate and Mortality Rate of ( ) Communicable Diseases per Population in Malaysia, ,665 new TB cases (mean ~ 46 cases /day) 1460 TB death (mean ~ 4 death/day) Source: Ministry of Health, 008 COMMUNICABLE DISEASES INCIDENCE RATE MORTALITY RATE AIDS HIV (all forms) Chancroid Cholera Dengue fever Dengue Haemorrhagic fever Diphteria Dysentry Food Poisoning Gonoccocal Infection Leprosy Malaria Measles Plague Polio Myelitis Rabies Relapsing Fever Syphillis Tetanus Neonatorum Tetanus (Adult) Tuberculosis Typhoid and Paratyphoid Typhus Viral Enchepalitis Viral Hepatitis Whooping cough Yellow fever Hand Foot and Mouth Ebola
6 Top 5 Communicable Disease, Malaysia ( ) Disease Incidence Mortality Incidence Mortality Incidence Mortality Rate Rate Rate Rate Rate Rate Dengue Fever Tuberculosis Hand, Food & Mouth Diseases Food Poisoning Malaria Source: Ministry of Health, 014 Note: *Incidence Rate was per 100,000 population except for Malaria per 10,000 population *Mortality Rate was per 100, population except for Malaria per 10, population 6
7
8 BCG vaccination coverage: 98% DOTS coverage: 98% XDR/MDRTB cases: Success treatment rate: 85% 100,000 po opulation Rate per Year Incidence rate of TB in Malaysia Source: TBIS, Ministry of Health, 015
9
10 TB Projection in Malaysia Nu umber of TB case es Projection of TB cases Retrospective projection of TB cases Time/year Source: Ismail N et al. 01
11 Contents 1. Introduction. Methods 3. Results 4. Discussion 11
12 Study Profile Study design/approach: infectious disease mathematical modelling Study and target population: Malaysian population Main Data Sources: Tuberculosis Information System (TBIS), Ministry of Health, Malaysia (data from ) International Union Against Tuberculosis & Lung Disease (IUATLD) WHO and World Bank Model system: deterministic, compartmental, ta SEIR Numerical analysis system: ODE, 4 th order Runge Kutta (RK4) iterative method Modelling Software: ModelMaker 4, Berkeley Madonna 1
13 Refinement of Model Homogenous model Age-structured model Gender-structured model 13
14 Contents 1. Introduction. Methods 3. Results 4. Discussion 14
15 Transmission of TB and Interventions Non-infected Persons Early y diagnosis Current treatment regimes Infectious TB Cases Infected Persons (LTBI) High Risk Infected Persons Identify with TST/IGRA Intervention (IPT)
16 The Tuberculosis Transmission Dynamic Model for Malaysia ٨ µ µ S δ k x R λ p r µ L E αd p (1 α)k t I µ L L δ 1 k x d n µ + µ t
17 DIFFERENCE EQUATIONS DIFFERENTIAL EQUATIONS S t+1 = ٨ t N+ (1 - βi t - µ t )S t LE t+1 = βi t S t + δ kx t R t + (1 - µ t - αdp t kt t + αkt t )LE t LL t+1 = (1 α)kt t LE t + (1 - δ 1 kx t - µ t - dn t )LL t I t+1 = αdp t LE t + δ 1 kx t LL t + dn t LL t + p t R t + (1 - µtb t - µ t - r t )I t R t+1 = r t I t + (1 - p t - µ t - δ kx t )R t
18 Various states of population in tuberculosis transmission dynamic of the model State Descriptions Assumptions S L E L L Number of susceptible individuals Number of early latent tuberculosis infected individuals Number of late latent tuberculosis infected individuals History of contacts within the first 5 years of exposure regardless of prior exposure status. Includes exogenous reinfection i.e. those reinfected following successful treatment (recurrent exposure) History of contacts more than 5 years of exposure I Number of infectious tuberculosis cases Equates annual incidence of tuberculosis at t time R Number of those recovered from tuberculosis following successful treatment *N Total population N equals to total Malaysian population i.e. aggregation of all other states at time t, N(t) () = S(t) () + LE(t) () + LL(t) () + I(t) + R(t) 18
19 List of parameters used in the model (1) Parameter Descriptions & Assumptions Value/Unit Reference ٨ Recruitment rate. Equates only birth rate. BCG immunization does not play any role in this type of tuberculosis transmission dynamic µ Mortality rate due to other causes. The annual crude death rate minus µ t 0.03/year 0.015/year Malaysian Department of Statistic 009; Malaysian MOH, 009 Malaysian Department of Statistic 009; Malaysian MOH, 009 µ t Mortality rate due to infectious tuberculosis. 0.1/year Malaysian MOH, 009 Takes into account the national TB death notification rate and does not include those with successful treatment λ Force of infection, taking into account frequency dependent mechanism or mass action with homogenous mixing: λ = Probability of effective tuberculosis transmission derivatives according to age and gender 0.35 Dye et al., 1998 c Per capita contact rate 10/year Malaysian MOH, 009 α Probability of those who develop primary infection within 5 years of exposure 0.07 Dye et al., 1998 k t Rate of progression of those who have been infected yet to develop the disease into late latent group 0./year Dye et al., 1998 k x Rate of exogenous reinfection. Exogenous reinfection rate k x defined as k x =aλ where a is the co-efficient of exogenous reinfection and similar infection and reinfection rate, a = 1 derivatives according to age and gender 19
20 List of parameters used in the model () Parameter Descriptions & Assumptions Value/Unit Rf Reference δ 1 k x Rate of exogenous reinfection where individuals at the state of late latent infection where δ 1 is the coefficient of the first pathway of exogenous reinfection and δ 1 k x = δ k x 0.75/year Styblo K., 1986; Comstock G.W., 198; Verver S., 005 δ k x d p d n r p Rate of recurrent infection of tuberculosis following successful treatment (recurrent exposure). where δ is the coefficient of the second pathway of exogenous reinfection and δ 1k x = δ k x Rate of developing infectious tuberculosis from early latent state (primary infection) Rate of developing infectious tuberculosis from late latent group via reactivation (endogenous route) Rate of effective treatment of those with infectious tuberculosis Rate of relapse for tuberculosis. Relapse back kto infectious state t regardless of bacteriological status 0.75/year Styblo K., 1986; Comstock G.W., 198; Verver S., /year Vynnycky & Fine, /year Vynnycky & Fine, /year Malaysian MOH, /year Malaysian MOH, 007 Θ Rate of effective IPT for early LTBI. Individuals in the early latent (L E ) who do not progress into infectious state due to effective treatment of Isoniazid preventive therapy 0.03/year Model output π Rate of effective IPT for late LTBI. Individuals in late latent (L L ) who do not progress into infectious state due to effective treatment of Isoniazid preventive therapy 0.007/year Model output 0
21 The optimized and best-fitted model showing predicted tuberculosis cases against observed tuberculosis cases in Malaysia from 1990 till 010 indicated as blue line (Inftotal) and red dots (Case Notifications) respectively. The lower and upper border projections of the model are also shown as pink dot-dash line (minimum) and green dash line (maximum) respectively. The optimization statistics derived using Marquardt method yield r = , p<
22 TB Projection in Malaysia Nu umber of TB case es Projection of TB cases Retrospective projection of TB cases Time/year Source: Ismail N et al. 01
23 TB Projection in Malaysia Nu umber of TB case es Observed number of TB cases Projection of TB cases Retrospective projection of TB cases Time/year Source: Ismail N et al. 01
24 Estimates and Projection based on TB notification data in Malaysia from Inftotal Case Notifications ases Num mber of TB c Year Using data between , the annual mean difference or underrepresentation is 13.11% (95%CI: 10.40;16.58)
25 Estimates and Projection based on TB notification data in Malaysia from Inftotal Case Notifications Using predicted data between and notification data between , the annual mean difference or underrepresentation is 13.49% (95%CI: )
26 TB Underrepresentation in Malaysia, TB underrerepresentation % Year Distribution ib i of annual mean difference or underrepresentation % between The mean difference or underrepresentation range is between 13.11% 13.49%
27 Contents 1. Introduction. Methods 3. Results 4. Discussion 7
28 Underrepresentation is common Quantification provides evidence Knowledge for Evidence based planning and policy Targeted/selective programme Problem solving
29 Thank you for your attention Other research supporting members: Dr Mohamed Paid Yusof, Disease Control Division, MOH Dr Fuad Hashim, Institute of Public Health, MOH Dr Mariam bt Mohamad, UiTM Selayang Campus Dr Badrul Hisham Abd Samad, Johor State Health Dept, MOH Dr Mokhtar bin Pungut, Segamat District Health Dept, MOH Dr Mohd. Yusof bin Hashim, Seberang Prai District Health Dept Dato Dr Haji Abdul Razak Muttalif, Inst. of Resp Medicine Datuk Dr Hjh Aziah bt Ahmad Mahayiddin, Inst. Resp Medicine Assoc. Prof. Dr Pang Yong Kek, UMMC Dr Karina Razali, HART Consultancy Acknowledgement: Director General of Health, Ministry of Health Disease Control Division, Ministry of Health Institute of Respiratory Medicine, Ministry of Health
30 The Tuberculosis Transmission Dynamic Model for Malaysia ٨ µ µ S δ k x R λ p r L θ L αd E p µ (1 α)k t I ϕ µ L L δ 1 k x d n µ + µ t
31 Model development Framework (scope, epidemiology, heterogeneity) Data collection and analysis of parameters (year ) Model baseline output Model validation (optimization, fitting & comparability) Model application Model used as a tool Estimate and projection of tuberculosis burden in Malaysia Effectiveness of potential intervention strategies Quantification of effectiveness of IPT (coverage) as a combined strategy Selection of LTBI for optimal coverage Overall potential impact of IPT combined strategy Formulation of policy recommendation Translation of model outputs to reality Recommendation of evidence for implementation Integration into current management protocol & health system Return on investment (ROI) Informed decision making 31
32 TB Situation TB Burden Ranking TB among HCW Diseas e Number of cases Incidence rate (IR) Dengue Infection 14, , , , , TB 15, , , , , , FP 6, , , , , , HFMD 1, ,35 5,141 1,558 15, HIV 6, , , , , , TB among Immigrant TB HIV Co infection 14 Peratus kes TB di kalangan wagra asing, %
33 TB Situation TB in Malaysia vs ASEAN Country TB Cases and IR Country No. of IR Estimated Estimated % TB Cases and Incidence Rate Diseas Number of cases cases No. of IR case e Incidence rate (IR) cases detection Brunei Dengue 66 14, ,86 17,147 3,310 46, Singapore Infection TB 15,58 15,49 15,991 16,665 16,918 17, Malaysia FP 6,64 5,957 4,641 6,938 14,455 17, Thailand HFMD 1, ,35 5, ,558 15, Indonesia HIV ,756 6,47 6,10 5,830 4,577 4,577 Year s No.of cases 0 IR/100,000 TB among Children Death AssociatedwithTB Percentag ge Year Year Death Rate (per 100,000 population) Target: <3 per 100,000 population r 100,000 la tio n Rate per popu
34 TBHIV in TB : ,0 10,0 8,0 % TBHIV in TB ,0 4,0,0 0,0 No of Cases No.TB cases Number Of New TB Cases With HIV Positive %TBHIV intb Year
35 The optimized and best-fitted model for predicting tuberculosis in Malaysia. The optimization statistics derived using Marquardt method yield r = , p<
Contents. Mathematical Epidemiology 1 F. Brauer, P. van den Driessche and J. Wu, editors. Part I Introduction and General Framework
Mathematical Epidemiology 1 F. Brauer, P. van den Driessche and J. Wu, editors Part I Introduction and General Framework 1 A Light Introduction to Modelling Recurrent Epidemics.. 3 David J.D. Earn 1.1
More informationNotifiable Infectious Diseases in Ireland 2001
Notifiable Infectious Diseases in Ireland 2001 Table 1. Annual number of infectious diseases notified in Ireland, 1982-2001 Infectious Disease 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993
More informationDeterministic Compartmental Models of Disease
Math 191T, Spring 2019 1 2 3 The SI Model The SIS Model The SIR Model 4 5 Basics Definition An infection is an invasion of one organism by a smaller organism (the infecting organism). Our focus is on microparasites:
More informationModule 5: Introduction to Stochastic Epidemic Models with Inference
Module 5: Introduction to Stochastic Epidemic Models with Inference Instructors: Tom Britton, Dept. Mathematics, Stockholm University Ira Longini, Dept. Biostatistics, University of Florida Jonathan Sugimoto,
More informationHealth Questionnaire
Health Questionnaire The information collected in this document is solely for the purpose of obtaining that which is required under the Ambulance Act of Ontario and is a condition of employment for all
More informationModule 5: Introduction to Stochastic Epidemic Models with Inference
Module 5: Introduction to Stochastic Epidemic Models with Inference Instructors:, Dept. Mathematics, Stockholm University Ira Longini, Dept. Biostatistics, University of Florida Jonathan Sugimoto, Vaccine
More informationAn Overview Of The Communicable Disease Situation In Singapore, 2000
An Overview Of The Communicable Disease Situation In Singapore, 2000 Communicable Disease Disease Situation In Singapore, 2000... 1-1 I AN OVERVIEW OF THE COMMUNICABLE DISEASE SITUATION IN SINGAPORE, 2000
More informationModelling BCG vaccination in the UK: What is the impact of changing vaccination policy?
Modelling BCG vaccination in the UK: What is the impact of changing vaccination policy? Sam Abbott Supervisors: Hannah Christensen, Ellen Brooks-Pollock University of Bristol 1 1. Lambert, M. L., Hasker,
More informationEpidemiological News Bulletin
PUBLICATION OF THE COMMITTEE ON EPIDEMIC DISEASES Epidemiological News Bulletin SEPTEMBER 2003 VOL. 29 NO. 9 ISSN 0218-0103 A laboratory-acquired case of severe acute respiratory syndrome A probable case
More informationInfectious Disease Surveillance System in Korea. Byungguk Yang Korea Centers for Disease Control and Prevention
Infectious Disease Surveillance System in Korea Byungguk Yang Korea Centers for Disease Control and Prevention 1 General information About Korea About KCDC (Korea Centers for Disease Control and Prevention)
More informationCholera. Cholera prevention and control. Mode of Transmission. Ganges River Delta. Public health significance
* This presentation is prepared by the author in one s personal capacity for the purpose of academic exchange and does not represent the views of his/her organisations on the topic discussed. Cholera prevention
More informationLAO PEOPLE'S DEMOCRATIC REPUBLIC
COUNTRY HEALTH INFORMATION PROFILE LAO PEOPLE'S DEMOCRATIC REPUBLIC WESTERN PACIFIC REGION HEALTH BANK, 2011 Revision Demographics 1 Area (1 000 km2) 236.80 2009 1 2 Estimated population ('000s) 6128.00
More informationTime to implement: WHO guidelines on TB Preventive Treatment
Time to implement: WHO guidelines on TB Preventive Treatment WHO End TB Strategy TARGETS: 90% reduction of deaths and 80% reduction in incidence by 2030 Early diagnosis Integrated, of TB including universal
More informationThe Medical Council of Hong Kong. Licensing Examination Part II - Proficiency Test in Medical English. Sample Test Paper.
The Medical Council of Hong Kong Licensing Examination Part II - Proficiency Test in Medical English Sample Test Paper Answer Book QUESTION I Circle the word TRUE or FALSE Note : One mark will be awarded
More informationInfectious disease modeling
Infectious disease modeling Matthew Macauley Department of Mathematical Sciences Clemson University http://www.math.clemson.edu/~macaule/ Math 4500, Spring 2017 M. Macauley (Clemson) Infectious disease
More informationMANITOULIN-SUDBURY DSB
MANITOULIN-SUDBURY DSB Pre-Employment Package Paramedic Hire Manitoulin-Sudbury District Services Board 2019 To be considered for Paramedic recruitment this pre employment package must be fully completed
More informationThe epidemiology of tuberculosis
The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications
More informationCOMMUNICABLE DISEASES SURVEILLANCE SYSTEM IN BULGARIA
COMMUNICABLE DISEASES SURVEILLANCE SYSTEM IN BULGARIA Episouth First Training module Madrid, 10-14 September, 2007 Dr. Kremena Parmakova Dr. Teodora Georgieva Bulgaria BULGARIA MAIN CITIES AND NEIGHBORING
More informationWESTERN PACIFIC REGION HEALTH DATABANK, 2011 Revision. Total
COUNTRY HEALTH INFORMATION PROFILE CHINA WESTERN PACIFIC REGION HEALTH BANK, 2011 Revision Demographics 1 Area (1 000 km2) 9600.00 2010 1 2 Estimated population ('000s) 1370537.00 686853.00 652872.00 2010
More informationOVERVIEW OF COMMUNICABLE DISEASE SURVEILLANCE SYSTEM IN BULGARIA
OVERVIEW OF COMMUNICABLE DISEASE SURVEILLANCE SYSTEM IN BULGARIA VIRAL HEPATITIS PREVENTION BOARD MEETING SOFIA, BULGARIA 24-25 MARCH 2011 Prof. Mira Kojouharova National Consultant on Epidemiology BULGARIA
More information1. INTRODUCTION. 1.1 Standard Precautions
1. INTRODUCTION 1.1 Standard Precautions Standard precautions, originally known as universal precautions, are essential components in preventing the transmission of infectious diseases in the healthcare
More informationThe Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific
Health System Strengthening and Sustaining the Response The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific Jintana Ngamvithayapong-Yanai, Ph.D. On behalf of TB/HIV Working Group, the
More informationIPT IMPLEMENTATION- SWAZILAND EXPERIENCE
IPT IMPLEMENTATION- SWAZILAND EXPERIENCE Gugu Mchunu-National TB/HIV coordinator Programmatic Management of Latent TB infection consultation meeting Seoul, Republic of Korea,27-28 APRIL,2016 TB Epidemiology
More informationMathematical Modeling of Hand-Foot-Mouth Disease: Quarantine as a Control Measure
E S Scholars www.setscholars.org T Knowledge is Power April 2012 Volume 1, Issue 2 Article #04 IJASETR Research Paper ISSN: 1839-7239 Mathematical Modeling of Hand-Foot-Mouth Disease: Quarantine as a Control
More informationWESTERN PACIFIC REGION HEALTH DATABANK, 2011 Revision. Total Total. Number of new cases. Total
COUNTRY HEALTH INFORMATION PROFILE WESTERN PACIFIC REGION HEALTH BANK, 2011 Revision Demographics 1 Area (1 000 km2) 299.76 1 2 Estimated population ('000s) 94 013.20 47 263.60 46 749.60 2010 est 2 3 Annual
More informationNotifiable Disease Surveillance in Fiji
Notifiable Disease Surveillance in Fiji Dave Saunders Assistant Epidemiologist, Ministry of Health and Social Welfare, Suva, FIJI Abstract Fiji s Ministry of Health provides free or very low cost health
More informationThe Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific
Health System Strengthening and Sustaining the Response The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific Jintana Ngamvithayapong-Yanai, Ph.D. On behalf of TB/HIV Working Group, the
More informationKingdom of Saudi Arabia Ministry of Education Umm Al-Qura University Health Sciences College at Al-Leith Department of Public Health
Kingdom of Saudi Arabia Ministry of Education Umm Al-Qura University Health Sciences College at Al-Leith Department of Public Health Introduction to Epidemiology Dr. Mohammed Ahmed Elawad Dr. Faleh Saud
More informationHEALTH REQUIREMENTS AND SERVICES: FFAD COMMUNICABLE DISEASES (EXHIBIT) REQUIREMENTS FOR EXCLUDING STUDENTS AND REPORTING CONDITIONS
REQUIREMENTS FOR EXCLUDING STUDENTS AND REPORTING CONDITIONS The information on the chart below has been collected from Department of Health rules at 25 TAC 97.3, 97.6, 97.7, and 97.132 The major criterion
More informationPAPUA NEW GUINEA 330 COUNTRY HEALTH INFORMATION PROFILES. WESTERN PACIFIC REGION HEALTH DATABANK, 2011 Revision. Female. Total. Male.
COUNTRY HEALTH INFORMATION PROFILE PAPUA NEW GUINEA WESTERN PACIFIC REGION HEALTH BANK, 2011 Revision Demographics 1 Area (1 000 km2) 462.84 2010 1 2 Estimated population ('000s) 6744.96 3478.10 3266.85
More informationTB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director
TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition
More informationAdolescent vaccination strategies
Adolescent vaccination strategies Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases & Molecular Medicine University of Cape Town www.vacfa.uct.ac.za gregory.hussey@uct.ac.za
More informationStructured models for dengue epidemiology
Structured models for dengue epidemiology submitted by Hannah Woodall for the degree of Doctor of Philosophy of the University of Bath Department of Mathematical Sciences September 24 COPYRIGHT Attention
More informationDHHS 2124 (Revised 7/03) EPIDEMIOLOGY. Hemorrhagic Fever (68)] Causative Organism: [Encephalitis, arboviral (9), Other Foodborne Disease (13), Viral
Reporters should indicate in the "COMMENTS" section the source of infection, if known, particularly for foodborne diseases. This area of the card is used by State or local health department staff to identify
More informationPrinciple of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos
Principle of Tuberculosis Control CHIANG Chen-Yuan MD, MPH, DrPhilos Estimated global tuberculosis burden 2015 an estimated 10.4 million incident cases of TB (range, 8.7 million 12.2 million) 142 cases
More informationLatest developments in WHO estimates of TB disease burden
Latest developments in WHO estimates of TB disease burden WHO Global Task Force on TB Impact Measurement meeting Glion, 1-4 May 2018 Philippe Glaziou, Katherine Floyd 1 Contents Introduction 3 1. Recommendations
More informationPresentation Overview
COMMUNICABLE DISEASE SURVEILLANCE IN VIETNAM: CURRENT SITUATIONS AND CHALLENGES ARF WORKSHOP ON DISEASE DETECTION AND SURVEILLANCE 13-15, September 2011, Manila, Philippine Tran Nhu Duong, MD National
More informationDaily Programme 6 th July 2012, Friday
6 th July 2012, Friday 0700 0800 Registration 0800 0805 Welcome by Dr Hooi Lai Ngoh, Chairperson, Organising Committee 0805 0810 Opening Remarks by Prof Dr Roslina Abdul Manap, President, Malaysian Thoracic
More informationProgrammatic management of latent TB infection: Global perspective and updates. Haileyesus Getahun, MD, MPH, PhD.
Programmatic management of latent TB infection: Global perspective and updates Haileyesus Getahun, MD, MPH, PhD. What is latent TB infection? A state of persistent immune response to stimulation by Mycobacterium
More informationDownloaded from
Class IX: Biology Chapter: Why do we fall ill Chapter Notes Key learnings: 1) Our body s well-being is dependent on the proper functioning of its cells and tissues. 2) All our body parts and activities
More informationApplication of Optimal Control to the Epidemiology of Dengue Fever Transmission
Application of Optimal Control to the Epidemiology of Dengue Fever Transmission Okey Oseloka Onyejekwe * Ayalnesh Tigabie Shiferaw Computational Science Program, Addis Ababa University, Arat Kilo Campass,Addis
More informationSanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines
Sanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines 1 Vaccines: the single most effective medical intervention 2 Vaccines save lives Millions of cases
More informationThe Communicable Disease Control Regulations
COMMUNICABLE DISEASE CONTROL 1 The Communicable Disease Control Regulations Repealed by Chapter P-37.1 Reg 11 (effective April 17, 2003). Formerly Chapter P-37.1 Reg 4 (effective January 1, 1997). NOTE:
More informationStatistical Appendix. List of tables
Statistical Appendix List of tables A1 Sociodemographic summary: by locality/chp A2 Estimated population: by age group and locality/chp A3 Projected population: by age group and sex A4 Births: by year
More informationInfectious Diseases Weekly Report. 14 March 2013 / Number 10
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 14 March / Number 10 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
More informationOutbreak preparedness and the NICD 24-hour hotline a review of calls made to the Hotline, and Outbreak Response Unit, July 2016-June 2017
Outbreak preparedness and the NICD 24-hour hotline a review of calls made to the Hotline, and Outbreak Response Unit, July 2016-June 2017 FIDSSA 2017 Kerrigan McCarthy, Nevashan Govender, Vivien Essel,
More informationA study on notifiable diseases reported in a tertiary care hospital
International Journal of Community Medicine and Public Health Asaithambi A et al. Int J Community Med Public Health. 2017 May;4(5):1656-1660 http://www.ijcmph.com pissn 2394-6032 eissn 2394-6040 Original
More informationThe roadmap. Why do we need mathematical models in infectious diseases. Impact of vaccination: direct and indirect effects
Mathematical Models in Infectious Diseases Epidemiology and Semi-Algebraic Methods Why do we need mathematical models in infectious diseases Why do we need mathematical models in infectious diseases Why
More informationPredictive values of IGRAs and TST for progression to active disease in TB. 3 rd Global IGRA Symposium January 2012.
Predictive values of IGRAs and for progression to active disease in TB contacts in Singapore Cynthia B E Chee 1, K W KhinMar 1, S H Gan 1, J Cutter, T M Barkham, Y T Wang 1 1 TB Control Unit, Tan Tock
More informationLatent TB Infection in the WHO European Region and recommendations on LTBI s M&E framework
Latent TB Infection in the WHO European Region and recommendations on LTBI s M&E framework 18 th Wolfheze workshops / 15 th NTP managers meeting, 31 May 02 June 2017 Dr Andrei DADU Technical officer, Joint
More informationInfectious Diseases Weekly Report. 12 January 2018 / Number 1. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 12 January / Number 1 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
More informationStatistical Appendix. Annual Report document. Public Health 2016/17
Statistical Appendix List of tables A1 Sociodemographic summary: by locality/hscp A2 Estimated population: by age group and locality/hscp A3 Projected population: by age group and sex A4 Births: by year
More informationInfectious Diseases Weekly Report. 23 August 2018 / Number 33. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 23 August / Number 33 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
More informationInfectious Diseases Weekly Report. 8 November 2018 / Number 44. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 8 November / Number 44 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
More informationInfectious Diseases Weekly Report. 15 November 2018 / Number 45. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 15 November / Number 45 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
More informationInfectious Diseases Weekly Report. 14 March 2019 / Number 10. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 14 March / Number 10 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
More informationInfectious Diseases Weekly Report. 22 March 2019 / Number 11. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 22 March / Number 11 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
More informationInfectious Diseases Weekly Report. 28 March 2019 / Number 12. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 28 March / Number 12 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
More informationInfectious Diseases Weekly Report. 4 April 2019 / Number 13. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 4 April / Number 13 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
More informationInfectious Diseases Weekly Report. 11 April 2019 / Number 14. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 11 April / Number 14 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
More informationContact Investigation and Prevention in the USA
Contact Investigation and Prevention in the USA George D. McSherry, MD Division of Infectious Disease Penn State Children s Hospital Pediatric Section TB Center of Excellence Rutgers Global Tuberculosis
More informationInfec&ous Disease Surveillance and Control a=er WenChuan Earthquake, China, 2008
Infec&ous Disease Challenges following Natural Disasters among APEC Economies Infec&ous Disease Surveillance and Control a=er WenChuan Earthquake, China, 2008 NI Daxin, M.D. Director, Office of Disease
More informationModeling the Impact of Screening and Treatment on the Dynamics of Typhoid Fever
ISSN 1 746-7233, England, UK World Journal of Modelling and Simulation Vol. 14 (2018) No. 4, pp. 298-306 Modeling the Impact of Screening and Treatment on the Dynamics of Typhoid Fever Nkuba Nyerere 1
More informationThursday. Compartmental Disease Models
Thursday Compartmental Disease Models Model Formulation Major decisions in designing a model Even after compartmental framework is chosen, still need to decide: Deterministic vs stochastic Discrete vs
More informationClass 9 th Why do we fall ill?
Class 9 th Why do we fall ill? Health: health is a state of physical, mental and social well being. The health of all individuals is dependent on their physical environment, social environment, and their
More informationPRINCIPLES OF PREVENTION AND CONTROL OF INFECTIOUS DISEASES Concepts Prevention measures taken to healthy individuals before the onset of diseases.
PRINCIPLES OF PREVENTION AND CONTROL OF INFECTIOUS DISEASES Concepts Prevention measures taken to healthy individuals before the onset of diseases. Control (secondary prevention) measures taken after occurrence
More informationSession-1: Template for country presentation (EXISTING Indicators)
Session-1: Template for country presentation (EXISTING Indicators) Instruction This presentation is expected to provide Country perspective on use of following Existing indicators among the top 10 indicators
More informationLIST OF APPENDICES. Appendix B Ontario Regulation 558/91 Specification of Communicable Diseases
LIST OF APPENDICES Appendix A Ontario Regulation 199/03 Control of West Nile Virus Appendix B Ontario Regulation 558/91 Specification of Communicable Diseases Appendix C Ontario Regulation 559/91 Specification
More informationT two important changes in the presentation of
f±1:]l1 INFECTIOUS DISEASE NOTIFICATIONS, NSW August, 1990 INFECTIOUS DISEASES his issue of the Public Health Bulletin contains T two important changes in the presentation of infectious disease notifications
More informationCHAPTER AT A GLANCE. Science Class (SA-II)- IX
13 CHAPTER AT A GLANCE Health is a general condition of a preson s mind and body. According to WHO (World Health Organisation) health is a state of physical, metal and social well-being of a person. To
More informationPREDICTING THE FUTURE TREND OF DRUG-RESISTANT TUBERCULOSIS IN THAILAND: ASSESSING THE IMPACT OF CONTROL STRATEGIES
FUTURE TREND OF DR-TB IN THAILAND PREDICTING THE FUTURE TREND OF DRUG-RESISTANT TUBERCULOSIS IN THAILAND: ASSESSING THE IMPACT OF CONTROL STRATEGIES Hiroshi Nishiura 1,2, Kot Patanarapelert 1 and I Ming
More informationDEPARTMENT OF DEFENSE AFHSB Reportable Events Monthly Report
DEPARTMENT OF DEFENSE AFHSB Reportable Events Monthly Report July 2016 Report Description Reportable Events among all beneficiaries received from the Services over the past 5 years are used to create ranges
More informationDEPARTMENT OF DEFENSE AFHSB Reportable Events Monthly Report
DEPARTMENT OF DEFENSE AFHSB Reportable Events Monthly Report May 2016 Report Description Reportable Events among all beneficiaries received from the Services over the past 5 years are used to create ranges
More informationResponse to Treatment in Sputum Smear Positive Pulmonary Tuberculosis Patients In relation to Human Immunodeficiency Virus in Kano, Nigeria.
Response to Treatment in Sputum Smear Positive Pulmonary Tuberculosis Patients In relation to Human Immunodeficiency Virus in Kano, Nigeria. Yusuf Mohammed, Mukhtar Dauda, Ifeanyi Oyeyi TB/HIV Unit, International
More informationModelling HIV prevention: strengths and limitations of different modelling approaches
Modelling HIV prevention: strengths and limitations of different modelling approaches Leigh Johnson Centre for Infectious Disease Epidemiology and Research Background Models of HIV differ greatly in their
More information1. TIME. TIME comprises two models:
1. TIME TIME comprises two models: TIME Estimates: This module is used for producing estimated and projected values for key TB indicators. These TB indicators include: TB incidence (particularly its split
More informationPublic Health & Disasters. Handoyo Pramusinto
Public Health & Disasters Handoyo Pramusinto Morbidity from disaster Injuries Emotional stress Epidemic of disease Increase in indigenous diseases Effects of Disaster Health Problems Common to
More informationMODELLING INFECTIOUS DISEASES. Lorenzo Argante GSK Vaccines, Siena
MODELLING INFECTIOUS DISEASES Lorenzo Argante GSK Vaccines, Siena lorenzo.x.argante@gmail.com GSK IN A NUTSHELL GSK VACCINES - GLOBAL PRESENCE SIENA RESEARCH AND DEVELOPMENT (R&D) SITE EXPLORATORY DATA
More informationCommunicable Disease Report January 2019
Licking County Health Department Communicable Disease Report January This report contains information regarding suspected, probable, and confirmed cases of the diseases listed and are subject to change
More informationLast mile vaccine distribution to rural health centres. Faheem Merchant
Last mile vaccine distribution to rural health centres Faheem Merchant New Global Immunization Goals 2000 - Millennium Development Goal # 4 Reduce under 5 child mortality by 2/3 between 1990 and 2015.
More informationSelected vaccine introduction status into routine immunization
Selected introduction status into routine infant immunization worldwide, 2003 This report summarizes the current status of national immunization schedules in 2003, as reported by Member States in the /UNICEF
More informationEMERGING DISEASES IN INDONESIA: CONTROL AND CHALLENGES
Tropical Medicine and Health Vol. 34 No. 4, 2006, pp. 141-147 Copyright 2006 by The Japanese Society of Tropical Medicine EMERGING DISEASES IN INDONESIA: CONTROL AND CHALLENGES I NYOMAN KANDUN Recieved
More informationRelative Risk Estimation of Tuberculosis with Standardized Morbidity Ratio in Malaysia
Global Journal of Pure and Applied Mathematics. ISSN 0973-1768 Volume 12, Number 5 (2016), pp. 4011 4019 Research India Publications http://www.ripublication.com/gjpam.htm Relative Risk Estimation of Tuberculosis
More informationOUTCOME AND IMPACT LEVEL INTERVENTION LOGIC & INDICATORS HEALTH SECTOR WORKING PAPER: DRAFT - OCTOBER 2009
EC EXTERNAL SERVICES EVALUATION UNIT OUTCOME AND IMPACT LEVEL INTERVENTION LOGIC & INDICATORS HEALTH SECTOR WORKING PAPER: DRAFT - OCTOBER 2009 This working paper outlines a set of indicators at the outcome
More informationMODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit
MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative
More informationSession 1. The aims of immunisation, national policy and schedules. Quality Education for a Healthier Scotland
Session 1 The aims of immunisation, national policy and schedules Aim The aim of this session is to explain the aims of immunisation, and describe national policy and schedules Learning Outcomes At the
More informationReporting of Communicable Diseases
Purpose Audience Policy To establish a system for reporting communicable diseases that are of public health importance to County Health Departments as required by state law. Infection preventionists, physicians,
More informationINH Prophylaxis Therapy (IPT) should NOT be implemented for all HIV patients in the Asia Pacific
INH Prophylaxis Therapy (IPT) should NOT be implemented for all HIV patients in the Asia Pacific Thuy Le, MD DPhil Duke University School of Medicine, USA Oxford University Clinical Research Unit Hospital
More informationPREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal
PREVENTION OF TUBERCULOSIS Dr Amitesh Aggarwal 25 to 50 % of persons exposed to intimate contact with active PTB - latent infection with TB. Exposure to index case for 12 hours - high risk of infection.
More informationLicking County Health Department 2012 INFECTIOUS DISEASE REPORT
Licking County Health Department 212 INFECTIOUS DISEASE REPORT Narrative The Licking County Health Department (LCHD) made several improvements in 212 related to surveillance, investigations, case reports,
More informationTUBERCULOSIS CONTROL IN THE WHO WESTERN PACIFIC REGION In the WHO Western Pacific Region 2002 Report
TUBERCULOSIS CONTROL IN THE WHO WESTERN PACIFIC REGION 2000 Tuberculosis Control In the WHO Western Pacific Region 2002 Report World Health Organization Office for the Western Pacific Region iii TUBERCULOSIS
More informationGlobal overview of Communicable Diseases
Faculty of Medicine الصحة العامة (31505291) Health Public Lecture 14 Global overview of Communicable Diseases By Hatim Jaber MD MPH JBCM PhD 24-7-2018 1 1. The global health impact of mental health and
More informationUGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
MINISTRY OF HEALTH UGANDA TIOL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME Revised Strategic Plan 2015/16-2019/20 Monitoring and Evaluation Plan Narrative of the Operational, Budget and Technical Assistance
More informationImmunization Update & focus on meningococcal vaccine PART 1
Immunization Update & focus on meningococcal vaccine PART 1 Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases University of Cape Town www.vacfa.uct.ac.za Disclosures Received
More informationSurveillance Site Reporting Requirements for Infectious Diseases
Surveillance Site Reporting Requirements for Infectious Diseases Updated pril 2017 Training Materials produced by the Tuscarawas County Health Department utilizing the Ohio Department of Health Infectious
More informationMeasuring progress in global tuberculosis control: WHO Policy and Recommendations DRAFT
Measuring progress in global tuberculosis control: WHO Policy and Recommendations DRAFT IMPORTANT NOTE: The main policies and recommendations are summarized on page 6 (synthesis of recommendations for
More informationEpidemiology of Tuberculosis Denver TB Course
Epidemiology of Tuberculosis Denver TB Course Randall Reves, MD, MSc Volunteer Clinician Denver Metro TB Program and Division of Infectious Diseases, Department of Medicine University of Colorado Denver
More informationFINAL. Etiologic Agents & Related Information to Know. Chapter 21: Microbial Diseases of Skin and Eyes Page No. Know term "diphtheroids"...
10 th Edition Tortora FINAL Microbiology Etiologic Agents & Related Information to Know Chapter 21: Microbial Diseases of Skin and Eyes Know term "diphtheroids"................. 586 Agents of boils and
More informationDISEASE PREVENTION & ANTIMICROBIAL USE REDUCTION: IMPACT OF VACCINATION
DISEASE PREVENTION & ANTIMICROBIAL USE REDUCTION: IMPACT OF VACCINATION Anwar Hoosen Department of Medical microbiology University of Pretoria & Tswane Academic Division, NHLS 1 VACCINE ACHIEVEMENTS At
More information